Literature DB >> 31230677

Tapering of SSRI treatment to mitigate withdrawal symptoms.

Henricus G Ruhe1, Annemieke Horikx2, Mariëlle J P van Avendonk3, Bart F Groeneweg4, Hèlen Woutersen-Koch3.   

Abstract

Mesh：

Year:  2019        PMID： 31230677     DOI： 10.1016/S2215-0366(19)30182-8

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  6 in total

1.  Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.

Authors:  Ellen Van Leeuwen; Mieke L van Driel; Mark A Horowitz; Tony Kendrick; Maria Donald; An Im De Sutter; Lindsay Robertson; Thierry Christiaens
Journal:  Cochrane Database Syst Rev       Date:  2021-04-15

2.  Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum.

Authors:  Michael P Hengartner; Lukas Schulthess; Anders Sorensen; Adele Framer
Journal:  Ther Adv Psychopharmacol       Date:  2020-12-24

Review 3.  Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review.

Authors:  Anders Sørensen; Karsten Juhl Jørgensen; Klaus Munkholm
Journal:  Ther Adv Psychopharmacol       Date:  2022-02-11

Review 4.  The relationship between dose and serotonin transporter occupancy of antidepressants-a systematic review.

Authors:  Anders Sørensen; Henricus G Ruhé; Klaus Munkholm
Journal:  Mol Psychiatry       Date:  2021-09-21       Impact factor: 15.992

5.  Factors associated with relapse and recurrence of major depressive disorder in patients starting mindfulness-based cognitive therapy.

Authors:  Jessica M de Klerk-Sluis; Marloes J Huijbers; Stephan Löcke; Jan Spijker; Philip Spinhoven; Anne E M Speckens; Henricus G Ruhe
Journal:  Depress Anxiety       Date:  2021-11-09       Impact factor: 8.128

6.  Outcome of antidepressant drug discontinuation with taperingstrips after 1-5 years.

Authors:  Peter C Groot; Jim van Os
Journal:  Ther Adv Psychopharmacol       Date:  2020-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.